Carpal Tunnel Syndrome. Carpal tunnel syndrome
Conditions
Interventions
Intervention 1: Intervention group: Fasad group ( in addition to night splint for three months), will receive Osailem Vein Fasd(phlebotomy). Intervention 2: Control group: will receive Night Splint fo
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: All cases of moderate carpal tunnel syndrome in the range of 20 to 60 years old, whose disease was detected by the NCV test Pain and numbness in hand along with tingling Acceptance all parts of the consent form and signing it
Exclusion criteria
Exclusion criteria: Failure to cooperate in filling forms Carpal tunnel syndrome caused by other systemic diseases, such as hypothyroidism, diabetes, rheumatoid arthritis History of trauma or surgery within the carpal tunnel area Median nerve entrapment in areas other than carpal tunnel Pregnancy at the entrance phase of the research process History of recent treatments including physiotherapy, laser therapy or any injections in the carpal tunnel area over past 2 months History of diabetes (according to the patient's announcement) History of collagen vascular disease or coincidence with tenosynovitis confirmed by a rheumatologist Existence of progressive cancers or recent chemotherapy or radiotherapy Use of anticancer drugs, corticosteroids, immunosuppressive or cytotoxic drug Serious medical conditions, such as renal and cardiac failure, obesity or overweight (based on BMI). A severe type of disease based on (NCV) and its symptoms (tropical atrophy, permanent paresthesia, etc.) Anemia Presence of coagulopathy in the patient
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptom severity in the Boston Questionnaire. Timepoint: at the beginning of the study and at the end of the first month and the third month. Method of measurement: Boston questionnaire.;Functional status in the Boston Questionnaire. Timepoint: at the beginning of the study and at the end of the first month and the third month. Method of measurement: Boston questionnaire.;Pain based on VAS SCALE. Timepoint: at the beginning of the study and at the end of the first month and the third month. Method of measurement: VAS SCALE.;Median nerve involvement. Timepoint: at the beginning of the study and at the end of the third month. Method of measurement: NCV. | — |
Secondary
| Measure | Time frame |
|---|---|
| Symptom Severity and Functional Status of participants. Timepoint: At the beginning of survey-End of first month-End of third month. Method of measurement: Boston Questionnaire.;Severity of median nerve involvement in nerve strip testing. Timepoint: At the beginning-End of third Month. Method of measurement: NCV =Nerve Conduction Velocity.;Pain. Timepoint: At the beginning and at the end of both first and third month of study. Method of measurement: VAS SCALE. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactLeila Hashemi Chelavi
Shahid Beheshti University of Medical Sciences
Outcome results
None listed